Health Care & Life Sciences » Biotechnology | Cantabio Pharmaceuticals Inc.

Cantabio Pharmaceuticals Inc.

Cantabio Pharmaceuticals Inc.
Stock Exchange Other OTC
Market Cap
$627.27 K
Shares Outstanding
56.51 M
Public Float
44.36 M


1250 Oakmead Parkway
Sunnyvale California 94085
United States
Employees -
Updated 09/14/2018
Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company which engages in the commercialization of novel therapies and the intellectual property generated from the research and development activities for Parkinson's, Alzheimer's diseases, and any other related diseases. It focuses on identification and development of small molecule pharmacological chaperones targeting proteins that misfold and aggregated in vivo vivo levels of proteins which display loss of function during disease conditions. The company was founded by Gergely Toth on November 2015 and is headquartered in Sunnyvale, CA.


View All

Gergely Tóth
Chief Executive Officer & Director
Thomas Roger Sawyer
Chief Operations Officer & Director